Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy.
作者信息
Niscola Pasquale, Tendas Andrea, Scaramucci Laura, Giovannini Marco, Piccioni Daniela, de Fabritiis Paolo
机构信息
Hematology Division, S. Eugenio Hospital, Rome, Italy.
出版信息
Blood Res. 2014 Mar;49(1):65-6. doi: 10.5045/br.2014.49.1.65. Epub 2014 Mar 24.
Abstract
摘要
相似文献
1
Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy.在低甲基化治疗期间由慢性粒单核细胞白血病演变而来的急性髓系白血病。
Blood Res. 2014 Mar;49(1):65-6. doi: 10.5045/br.2014.49.1.65. Epub 2014 Mar 24.
2
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.非治愈性疗法治疗的慢性髓单核细胞白血病患者的结局：一项回顾性队列研究。
Lancet Haematol. 2021 Feb;8(2):e135-e148. doi: 10.1016/S2352-3026(20)30374-4.
3
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.异基因干细胞移植前使用去甲基化药物治疗可改善慢性粒单核细胞白血病患者的无进展生存期。
Biol Blood Marrow Transplant. 2016 Jan;22(1):47-53. doi: 10.1016/j.bbmt.2015.08.031. Epub 2015 Sep 4.
4
Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.老年人群慢性髓单核细胞白血病与骨髓增生异常综合征的治疗和结局比较。
Haematologica. 2013 Apr;98(4):584-90. doi: 10.3324/haematol.2012.062547. Epub 2012 Nov 9.
5
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.DNA 低甲基化剂作为骨髓增生异常综合征和幼年型粒单核细胞白血病异基因造血干细胞移植前后的表观遗传学治疗。
Semin Cancer Biol. 2018 Aug;51:68-79. doi: 10.1016/j.semcancer.2017.10.011. Epub 2017 Nov 9.
6
Case report of isochromosome 17q in acute myeloid leukemia with myelodysplasia-related changes after treatment with a hypomethylating agent.急性髓系白血病伴骨髓增生异常相关改变患者经去甲基化药物治疗后出现17号染色体等臂染色体的病例报告。
Genet Mol Res. 2012 Aug 6;11(3):2045-50. doi: 10.4238/2012.August.6.8.
7
Treatment advances for pediatric and adult onset neoplasms with monocytosis.伴有单核细胞增多的小儿和成人发病肿瘤的治疗进展。
Curr Hematol Malig Rep. 2021 Jun;16(3):256-266. doi: 10.1007/s11899-021-00622-8. Epub 2021 Mar 16.
8
Clinical update on hypomethylating agents.低甲基化剂的临床最新进展。
Int J Hematol. 2019 Aug;110(2):161-169. doi: 10.1007/s12185-019-02651-9. Epub 2019 Apr 24.
9
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.比较 70 岁及以上急性髓系白血病患者常用一线方案的生存结局。
Haematologica. 2020 Jan 31;105(2):398-406. doi: 10.3324/haematol.2018.208637. Print 2020.
10
Therapy for Chronic Myelomonocytic Leukemia in a New Era.新时代慢性粒单核细胞白血病的治疗
Curr Hematol Malig Rep. 2017 Oct;12(5):468-477. doi: 10.1007/s11899-017-0408-8.
引用本文的文献
1
Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?晚期慢性粒单核细胞白血病患者的一线治疗方法：去甲基化药物还是细胞毒性治疗？
Front Oncol. 2021 Dec 13;11:801524. doi: 10.3389/fonc.2021.801524. eCollection 2021.
2
Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia.阿扎胞苷成功长期治疗慢性粒单核细胞白血病患者。
Hematol Rep. 2020 Dec 2;12(3):8537. doi: 10.4081/hr.2020.8537.
本文引用的文献
1
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations.阿扎胞苷在骨髓增生异常综合征中的应用：争议问题与实用建议。
Blood Res. 2013 Jun;48(2):87-98. doi: 10.5045/br.2013.48.2.87. Epub 2013 Jun 25.
2
Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.由慢性髓单核细胞白血病继发的急性髓系白血病的临床病理分析。
Mod Pathol. 2013 Jun;26(6):751-61. doi: 10.1038/modpathol.2012.218. Epub 2013 Jan 11.
3
Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?阿扎胞苷治疗慢性粒单核细胞白血病：我们目前了解到了什么？
Leuk Res. 2013 Feb;37(2):204-5. doi: 10.1016/j.leukres.2012.10.023. Epub 2012 Nov 20.
4
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.使用5-氮杂胞苷治疗慢性粒单核细胞白血病的高缓解率：一项意大利回顾性研究的结果
Leuk Lymphoma. 2013 Mar;54(3):658-61. doi: 10.3109/10428194.2012.719617. Epub 2012 Aug 30.
5
Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.慢性髓单核细胞白血病：诊断、危险分层和治疗的 2012 年更新。
Am J Hematol. 2012 Jun;87(6):610-9. doi: 10.1002/ajh.23203.
6
Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review.5-氮杂胞苷治疗慢性粒单核细胞白血病：病例系列及文献复习。
Leuk Res. 2012 Aug;36(8):1071-3. doi: 10.1016/j.leukres.2012.04.024. Epub 2012 May 17.
7
Activity of azacitidine in chronic myelomonocytic leukemia.阿扎胞苷在慢性粒单核细胞白血病中的活性。
Cancer. 2011 Jun 15;117(12):2690-6. doi: 10.1002/cncr.25759. Epub 2010 Dec 23.
8
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).地西他滨治疗慢性粒单核细胞白血病（CMML）患者的疗效。
Leuk Res. 2008 Apr;32(4):587-91. doi: 10.1016/j.leukres.2007.08.004. Epub 2007 Sep 18.
9
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.慢性粒单核细胞白血病的预后因素及评分系统：213例患者的回顾性分析
Blood. 2002 Feb 1;99(3):840-9. doi: 10.1182/blood.v99.3.840.
Zotero 插件